AtriCure officer plans sale of 3,657 shares

An AtriCure officer filed a Rule 144 notice to sell 3,657 common shares, following a recent 7,763-share sale.

Available on EDGAR 09/08/2026 - 04:18 PM EDT Accepted by SEC EDGAR 09/08/2026 - 04:17 PM EDT Learn about SEC filing dates

Rhea-AI Filing Summary

AtriCure, Inc. (ATRC) is the issuer for which officer Salvatore Privitera has filed a notice of proposed sale of restricted securities under Rule 144. The planned sale covers 3,657 shares of common stock, with the broker listed as Morgan Stanley Smith Barney LLC and an intended sale date of September 8, 2026 on NASDAQ.

The shares to be sold trace to performance shares acquired on February 16, 2021 from the issuer. Over the preceding three months, the same person is reported as having sold 7,763 shares of AtriCure common stock on September 2, 2026 for an aggregate price of $407,557.50.

Key Figures

Shares to be sold under Rule 144: 3,657 shares Planned sale date: September 8, 2026 Shares sold in last three months: 7,763 shares +3 more

6 metrics

Shares to be sold under Rule 144 3,657 shares Planned sale of AtriCure common stock by officer Salvatore Privitera

Planned sale date September 8, 2026 Intended date of Rule 144 sale of 3,657 shares on NASDAQ

Shares sold in last three months 7,763 shares Sale of AtriCure common stock on September 2, 2026

Aggregate price of recent sale $407,557.50 Proceeds from 7,763 shares of AtriCure common stock sold on September 2, 2026

Acquisition date of performance shares February 16, 2021 Date the 3,657 performance shares were acquired from the issuer

Security type Common stock AtriCure, Inc. common stock subject to Rule 144 filing

Key Terms

Rule 144, Performance Shares, restricted securities

3 terms

Rule 144 regulatory

"See the definition of "person" in paragraph (a) of Rule 144."

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

Performance Shares financial

"Common | 02/16/2021 | Performance Shares | ISSUER"

Performance shares are a type of company stock given to executives or employees that only become theirs if the company meets specific goals, like hitting certain profits or growth targets. They motivate leaders to work toward the company’s success, because their additional shares depend on achieving these results.

restricted securities regulatory

"notice of proposed sale of restricted securities under Rule 144"

Restricted securities are shares or other investment instruments that come with legal or contractual limits on when and how they can be sold, like stock given to founders or bought in a private offering. Think of them as assets in a locked box that can’t be freely traded until certain conditions — such as a waiting period, company registration, or specific approvals — are met. For investors this matters because restricted securities are less liquid and can affect timing, price, and perceived value when they eventually enter the market.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does the Form 144 filing for ATRC disclose about upcoming sales?

The notice reports that officer Salvatore Privitera intends to sell 3,657 shares of AtriCure common stock through Morgan Stanley Smith Barney LLC, with an indicated sale date of September 8, 2026 on NASDAQ.

How many ATRC shares linked to the Form 144 were originally acquired and when?

The 3,657 shares covered by the planned sale are reported as performance shares acquired from the issuer on February 16, 2021. The filing identifies the acquisition type as “Performance Shares” and the source as the issuer.

What ATRC stock sales has the filer made in the last three months?

Over the past three months, Salvatore Privitera is listed as having sold 7,763 shares of AtriCure common stock on September 2, 2026 for an aggregate sale price of $407,557.50.

Who is the person selling ATRC shares under this Form 144 and what is their role?

The person for whose account the securities are to be sold is Salvatore Privitera, identified in the filing as an officer of AtriCure, Inc. The notice is provided under Rule 144 for resales of restricted or control securities.

Which broker is handling the planned ATRC Rule 144 sale?

The filing lists Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, as the broker for the sale of 3,657 shares of AtriCure common stock to be traded on NASDAQ.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001336063
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	ATRICURE, INC.
SEC File Number	000-51470
Address of Issuer	7555 Innovation Way Mason OHIO 45040
Phone	(513) 755-4100
Name of Person for Whose Account the Securities are To Be Sold	SALVATORE PRIVITERA
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	3657	201135.00	50866294	09/08/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	02/16/2021	Performance Shares	ISSUER			3657	02/16/2021	Not Applicable

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
SALVATORE PRIVITERA 7555 Innovation Way Mason OH 45040	Common	09/02/2026	7763	407557.50

144: Remarks and Signature

Remarks
Date of Notice	09/08/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	02/20/2026
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Salvatore Privitera
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)